Mental Health Clinics in Oscoda, MI Accepting Medicare
5 Mental Health Clinics found. Showing 1 - 5
 Alcona Health Center-oscoda Services Counselor Medicare: Medicare Enrolled Practice Location: 208 S State St, Oscoda, MI 48750 Phone: 989-739-2550 Fax: 989-358-3750 |
Turning Point Counseling, Inc. Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 5671 N Skeel Ave Ste 7, Oscoda, MI 48750 Phone: 989-747-0420 Fax: 989-747-0422 |
Ahc Oscoda Area High School Social Worker - School Medicare: Not Enrolled in Medicare Practice Location: 3550 E River Rd, Oscoda, MI 48750 Phone: 989-739-9121 |
North Shores Center, Llc Clinic - Adult Mental Health Medicare: Not Enrolled in Medicare Practice Location: 6193 Norway Rd, Oscoda, MI 48750 Phone: 989-569-3772 |
Monarch Behavioral Services, Llc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 111 E Dwight St Ste 1, Oscoda, MI 48750 Phone: 989-305-1932 |
News Archive
Intellipharmaceutics files generic 30 mg Focalin XR ANDA with FDA
Intellipharmaceutics International Inc., today announced that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for approval to market a generic of the 30 mg strength of Focalin XR® (dexmethylphenidate hydrochloride). The application for the 30 mg strength is filed as an amendment to the ANDA that Intellipharmaceutics had previously filed for the 5, 10, 15 and 20 mg strengths of the drug.
Hydroxyurea treatment for sickle cell underused by doctors
Uncertainties about proper use and possible long-term effects of hydroxyurea in the treatment of sickle cell anemia may be wrongly influencing doctors to avoid prescribing it to those in serious need, according to results of a literature review by specialists at Johns Hopkins.
Quest Diagnostics subsidiary initiates tender offer for Celera acquisition
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, announced today it has commenced a tender offer through its wholly owned subsidiary, Spark Acquisition Corporation, for all of the outstanding shares of common stock (the "Shares") of Celera Corporation (Nasdaq: CRA), one of the world's pioneers in genetic diagnostics discovery and development for $8.00 per share in cash, without interest and less any required withholding taxes.
Study highlights need for support services to address reproductive concerns of female cancer survivors
A new study indicates that many young adult female cancer survivors do not receive adequate information about their fertility as part of their survivorship care after completing treatment, despite having concerns about their ability to bear children in the future.
Safer sex communication in transgender adults is more complicated: Study
A new study from North Carolina State University shows that talking about safer sex is a complicated process for individuals in the transgender community. The finding may help efforts to promote safer sex practices in a community facing high HIV rates - and also sheds light on broader questions related to safer sex for everyone.
› Verified 2 days ago